Oral Disease-Modifying Treatments for Multiple Sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Reference127 articles.
1. The ups and downs of multiple sclerosis therapeutics
2. Current Disease-Modifying Therapies in Multiple Sclerosis
3. Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies
4. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines
5. New directions in MS therapeutics: vehicles of hope
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigating drug-induced urinary retention: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024;Expert Opinion on Drug Safety;2024-09-13
2. Lossen rearrangement by Rh(iii)-catalyzed C–H activation/annulation of aryl hydroxamates with alkynes: access to quinolone-containing amino acid derivatives;Organic & Biomolecular Chemistry;2021
3. Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges;Expert Review of Neurotherapeutics;2020-11-05
4. Synthesis of 3-substituted quinolin-2(1H)-onesviathe cyclization ofo-alkynylisocyanobenzenes;Organic & Biomolecular Chemistry;2018
5. Cancer specific risk in multiple sclerosis patients;Critical Reviews in Oncology/Hematology;2016-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3